HOME >> BIOLOGY >> NEWS
First International Scientific Conference on Childhood Leukaemia

CHILDREN with LEUKAEMIA Britain's leading charity dedicated exclusively to the conquest of childhood leukaemia is organising the first international scientific conference ever to be held into the incidence, causes and prevention of childhood leukaemia.

Major advances in treatment have seen a significant increase in 5-year survival rates from under 5% in the early 1960s to over 80% for the commonest type of childhood leukaemia. But, this success has come at a price. We now know that survivors face higher risks of developing another cancer or other potentially serious health problems. Another major worry is that the incidence of leukaemia in the under 5s is rising and we don't know why.

These concerns are bringing together international experts from Europe, Australia, Asia and the USA to present new data and to exchange information on every aspect of incidence, potential causes and possibilities for prevention. Topics from invited speakers include:

  • Time trends in incidence
  • Possible role of viruses and infections
  • Molecular mechanisms
  • Leukaemia clusters
  • Radiation including maternal and paternal exposure, CT scanning, radiation discharges, EMF, light emission..
  • Air pollution
  • Placental transfer to the foetus
  • Risk assessment, safety precautions and policy options
  • Future research priorities

There will also be poster presentations of further new data.

Registration is free for bona fide media on presentation of official press credentials at the conference press office or by pre-registering. You are welcome to attend all sessions.

A news briefing will be held on the opening morning (Monday 6 September). A second media alert with more details will be sent to you in due course.

In the meantime, visit http://www.leukaemiaconference.org/ for full details of
'"/>

Contact: Margaret Willson
44-015-367-72181
Children With Leukaemia
23-Jul-2004


Page: 1 2

Related biology news :

1. First glimpse of DNA binding to viral enzyme
2. First clinical study of new pediatric croup vaccine shows safety, tolerability in adults
3. 2nd media alert First Scientific Conference on Childhood Leukaemia
4. First ever standards linking climate change, biodiversity and poverty seek global peer review
5. First genetic comparison of purebred domestic dogs produces surprises
6. First time in the U.S.: Saint Louis University tests third-generation vaccine against smallpox
7. First target for childhood malaria vaccine
8. First study of resveratrol dietary supplement finds effect on breast and prostate cancers unlikely
9. First flavors form a lasting impression
10. STN International launches Derwent World Patents Index First View
11. First DFG research conference in the USA

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/19/2019)... ... November 19, 2019 , ... Project Lifeline – ... Stores (NACDS) Foundation to address substance use disorder (SUD) – will take ... who have led to the program’s effectiveness in preventing and treating opioid abuse in ...
(Date:11/14/2019)... ... ... Personalized Stem Cells, Inc (“PSC”), a human adipose-derived stem cell ... for stem cell treatment of knee osteoarthritis . The first treatment came shortly after ... Biopharma. , In July of 2019, PSC received FDA approval for a ...
(Date:11/12/2019)... ... 2019 , ... Atlantic Ultraviolet Corporation (AUV), the premier manufacturer ... their patented automatic and manual wipers the #1 best feature of the ... task required of an ultraviolet water purifier is quartz sleeve cleaning. A fouled ...
Breaking Biology News(10 mins):
(Date:11/2/2019)... ... October 31, 2019 , ... A ... communicating with each other: study managers, principal investigators, supply chain managers, manufacturers, IRT, ... is not informed of the latest data, potentially leading to patient risk. , ...
(Date:10/30/2019)... ... 30, 2019 , ... Western University of Health Sciences held ... play in educating the next generation of health care providers. , The event, ... WesternU administrators and representatives of companies working with the University on a range ...
(Date:10/26/2019)... ... October 24, 2019 , ... Sparks Marketing Group, Inc. ... (BMMG), a boutique healthcare-specific marketing firm, to strengthen the agency’s growing focus on ... , Healthcare clients in pharma, bio-therapeutics, medical device and healthcare technologies currently account ...
(Date:10/22/2019)... ... 2019 , ... DermBiont, a clinical stage microbiome biotechnology company ... primary safety endpoints, with no application site reactions and no adverse events, in ... interdigital tinea pedis (athlete’s foot). Additionally, the trial demonstrated a clinical response with ...
Breaking Biology Technology:
Cached News: